Sahin et al (24) reported that only 8% of glioma specimens expressed MAGE-A3, while Saikali et al (25) demonstrated that the MAGE-A3 mRNA expression frequency in glioblastoma multiforme was 42%. This evidence concerns the gene MAGEA3 and central nervous system cancer.